News

iOnctura Expands Leadership Team with Key Appointments

iOnctura Expands Leadership Team with Key Appointments

iOnctura Expands Leadership Team with Key Appointments

iOnctura, a dynamic figure in the biopharmaceutical landscape, has taken significant strides forward with the recent appointments of Elizabeth Holt as Chief Business Officer (CBO) and Dr. Mark Velleca as Chair of the Board of Directors. These strategic additions to the leadership team promise to drive the company's innovative approach to treating neglected and hard-to-treat cancers, marking an exciting phase in its growth journey.

Elizabeth Holt Takes the Helm as Chief Business Officer

Elizabeth Holt joins iOnctura with an impressive lineage of experience within life sciences partnerships. Her proven track record speaks volumes, as she has previously co-founded Aiolos Bio Inc., which was acquired for a remarkable total value. Elizabeth's strategic insights and knack for securing funds have been pivotal in her past roles, including significant contributions to Gyroscope Therapeutics, where her efforts helped propel the organization through its acquisition.

Before establishing her footprint in the biopharmaceutical realm, Elizabeth honed her expertise at McKinsey & Company, providing high-level advisory services to healthcare executives. Her academic roots are just as formidable, featuring an MBA from NYU Stern School of Business and an MSc from the prestigious London School of Economics.

Dr. Mark Velleca Appointed as Board Chair

Taking the reins as Chair of the Board of Directors, Dr. Mark Velleca is no stranger to leadership within the biopharmaceutical sector. As the current CEO and Board Chair of another leading therapeutic company, he brings a wealth of knowledge in drug development and strategic leadership. Mark's past accomplishments, including leading G1 Therapeutics to its public debut and steering the successful development of its first therapy, illustrate his capacity for innovation in the industry.

His medical and academic background as an attending physician at Yale and his tenure at Yale University School of Medicine further underscore his extensive experience. Holding both an M.D. and Ph.D. enhances his ability to navigate complex challenges within the realm of biopharmaceuticals.

Vision for iOnctura's Future

Catherine Pickering, CEO and co-founder of iOnctura, expressed her enthusiasm: 'Our leadership team is meticulously curated to guide iOnctura through the next chapter. Mark and Elizabeth's vast experiences will be instrumental in advancing our innovative pipeline, as we focus on the mission to improve outcomes for patients battling challenging cancers.'

The Pioneering Spirit at iOnctura

Both new appointees acknowledged the strategic vision and pioneering spirit at iOnctura. Elizabeth noted her attraction to the company's progress and leadership team. Her extensive background in clinical-stage biopharmaceuticals has positioned her well to contribute positively to the ambitious environment at iOnctura.

Dr. Velleca highlighted the unique aspects of iOnctura's lead asset, roginolisib, which stands out as an innovative allosteric modulator of PI3K?. He remains optimistic about developing this promising target, which is crucial in redefining the treatment landscape for patients in oncology categories.

About iOnctura

iOnctura is a forward-thinking precision oncology company dedicated to combating neglected and hard-to-treat cancers through a robust pipeline of first-in-class small molecules. The treatments under development are engineered to extend lives and enhance health spans, fundamentally changing the treatment trajectory for many patients and their families. Roginolisib, its flagship asset, operates under a fresh paradigm of allosteric modulation, ensuring targeted efficacy while minimizing previous tolerability concerns. Currently, roginolisib is engaged in several randomized Phase II studies, targeting both solid and hematological malignancies.

Headquartered in Amsterdam, with a subsidiary in Geneva, iOnctura is supported by a group of specialized institutional investors, positioning the company favorably for future growth and innovation.

Frequently Asked Questions

What recent appointments were made at iOnctura?

Elizabeth Holt has been appointed as Chief Business Officer, and Dr. Mark Velleca will serve as Chair of the Board of Directors.

What is Elizabeth Holt's professional background?

Elizabeth has extensive experience in life sciences partnerships and has previously co-founded successful companies, such as Aiolos Bio Inc.

Who is Dr. Mark Velleca?

Dr. Velleca is currently the CEO and Board Chair of Black Diamond Therapeutics and was formerly the CEO of G1 Therapeutics.

What is iOnctura's primary focus?

iOnctura is focused on developing treatments for neglected and hard-to-treat cancers through a unique pipeline of small molecules.

What distinguishes roginolisib in cancer treatment?

Roginolisib is an allosteric modulator of PI3K?, offering a new approach with the potential for improved tolerability compared to previous inhibitors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 90

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 34

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 67

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 112

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 84

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 118

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading
GEYOTO’s RE+ Debut Shows Demand, Not Yet Scale Proof

Updated Category News Views 39

Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 268

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading

Top 5 Most Recently Viewed Articles

Future of Crypto: Brian Armstrong on Innovative Payment Solutions

Updated Category News Views 292

Coinbase's Vision for Payments in the Crypto World Brian Armstrong, the CEO of Coinbase Global Inc. (NASDAQ: COIN), is optimistic about the role of payments as a transformative use case within the cryptocurrency landscape. In a recent discussion, he articulated how he believes this sector will significantly evolve, particularly in terms of integrating stablecoins into...

Continue Reading
Veeva Basics Empowering Biotechs to Enhance Efficiency and Growth

Updated Category News Views 185

Veeva Basics Revolutionizes Biotech Operations In today's fast-paced biotech landscape, efficient operations are crucial. Veeva Systems (NYSE: VEEV) has introduced Veeva Basics, a solution now adopted by over 100 emerging biotechs. With this innovative approach, these companies can simplify and standardize their operations, allowing them to focus on what truly matters:...

Continue Reading
Exploring the Rise of Small-Cap Stocks: A 2024 Overview

Updated Category News Views 613

Small-Cap Stocks Lead 2024 Gains In the vibrant market of 2024, small-cap stocks have shined brighter than ever, showcasing remarkable performance that has left traditional blue-chip stocks in their wake. While larger, well-known companies often dominate discussions, smaller firms are making headlines with exhilarating returns. Remarkable Returns in the Market This year,...

Continue Reading
Ridge Street Capital Signs Significant Growth in Lending Sector

Updated Category News Views 206

Ridge Street Capital's Impressive Growth in Investment Lending Ridge Street Capital, a dynamic private lending firm, is celebrating a remarkable achievement in its operation, reporting over 150% growth from one year to the next. This impressive advancement marks the firm as a key player in investment property financing, primarily due to its tailored approach and...

Continue Reading
Kuehn Law Advocates for Sarepta Therapeutics Shareholders

Updated Category News Views 153

Kuehn Law Advocates for Sarepta Therapeutics Shareholders Kuehn Law, PLLC, a law firm dedicated to shareholder litigation, is reaching out to investors of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) regarding pressing concerns that have surfaced about the company's internal practices. Recent investigations suggest that certain officers and directors possibly did not uphold...

Continue Reading